Henry Lu
Corporate Officer/Principal bei WUXI APPTEC CO., LTD.
Profil
Henry Lu is currently the Vice President & Head-Biology at WuXi AppTec Co., Ltd.
Prior to this, he worked as the Senior Director-Infectious Diseases at Rigel Pharmaceuticals, Inc. and as a Principal Scientist at Novartis Corp.
He also served as an Adjunct Associate Professor at The University of California, San Francisco.
Dr. Lu received his undergraduate degree from Fudan University and his doctorate from Academia Sinica.
Aktive Positionen von Henry Lu
| Unternehmen | Position | Beginn |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 03.08.2011 |
Ehemalige bekannte Positionen von Henry Lu
| Unternehmen | Position | Ende |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Ausbildung von Henry Lu
| Fudan University | Undergraduate Degree |
| Academia Sinica | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
